CG Oncology, Inc. Common stock (CGON) — the earnings record

Computed on 2026-09-18 from the vendor's per-print history with the Print Record's method — no desk-written read yet. An investment research diary, not advice.

The record at a glance

2/9EPS beats
7/9revenue beats
5 · 2 · 2up · flat · down (+3d, ±3%)
2026-11-13next print

Reactions across the covered prints span -15.8% to +6.6% — the beat column and the reaction column frequently disagree, which is the whole reason the record scores them separately. The street carries est EPS $-0.86 · est revenue ~$0.00B into the next print.

Print by print

PrintDateEPSRevenue
Aug 26 2026-08-06 ✗ miss ✓ beat
May 26 2026-05-08 ✗ miss ✓ beat
Feb 26 2026-02-27 ✓ beat ✓ beat
Nov 25 2025-11-14 ✗ miss ✓ beat
Aug 25 2025-08-08 ✗ miss ✗ miss
May 25 2025-05-13 ✗ miss ✗ miss
Mar 25 2025-03-28 ✗ miss ✓ beat
Aug 24 2024-08-08 ✓ beat ✓ beat
May 24 2024-05-09 ✗ miss ✓ beat

Report-day close to the close three sessions later on adjusted closes, ±3% bands — the same method as every hand-written card; the Print Record method explains the bands. No reaction chart, metric line or behavior read exists for CGON yet.

FAQ · from the current data · as of 2026-09-18

Quick answers

How often does CG Oncology, Inc. Common stock beat earnings estimates?

Across the last 9 covered prints (as of the 2026-09-18 card), CG Oncology, Inc. Common stock beat EPS estimates 2 of 9 times and revenue estimates 7 of 9 times, with 2 double beats.

How does CGON stock react to earnings?

Measured close-of-print-day to the close three sessions later: 5 of the last 9 prints resolved up (beyond +3%), 2 flat, 2 down — reactions spanning -15.8% to +6.6%. Beat-or-miss and reaction are scored separately because they frequently disagree.

What was CGON's biggest earnings reaction?

-15.8% over the three sessions after the Mar 25 print (2025-03-28).

When does CG Oncology, Inc. Common stock report earnings next?

2026-11-13 (2026-11-13 · est EPS $-0.86 · est revenue ~$0.00B). This record is computed from the vendor's per-print history with the Print Record's method; a desk-written card for CGON does not exist yet. An investment research diary, not advice.

Related in the Closelook universe

then Biotechnology. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.